Quick Summary:
In the dynamic world of healthcare, your success requires on-point insights and precise forecasting. With the potential to reach the $3 Billion mark by 2030, the Global Pediatric Interventional Cardiology Devices Market is a sector worth understanding. Our comprehensive market research report offers the expertise you need to capitalize on this rapidly expanding industry.
This report provides an extensive overview, dissecting segments such as Congenital Heart Defect Closure Devices and Transcatheter Heart Valves, in addition to in-depth country-specific analysis including key markets such as the U.S. and China. We have also carefully examined and profiled key competitors in this space. Moreover, the report features exclusive coverage on global competitiveness and significant competitor market shares, providing the strategy-defining competitive intelligence that drives growth. With this report, gain a robust understanding of the market presence across various geographies and stay on top pulse of this high-growth market. Acquisition of this report includes complimentary updates for one year, ensuring you are always equipped with real-time market insights.
Global Pediatric Interventional Cardiology Devices Market to Reach $3 Billion by 2030
The global market for Pediatric Interventional Cardiology Devices estimated at US$2.2 Billion in the year 2022, is projected to reach a revised size of US$3 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2022-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Transcatheter Heart Valves segment is readjusted to a revised 4.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $580.8 Million, While China is Forecast to Grow at 7.9% CAGR
The Pediatric Interventional Cardiology Devices market in the U.S. is estimated at US$580.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$691.3 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.Select Competitors (Total 41 Featured) -
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Edwards Lifesciences Corporation
- GE Healthcare
- Medtronic PLC
- Siemens AG
- W. L. Gore & Associates, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Pediatric Interventional Cardiology Devices?
What is the growth rate of the Global Market for Pediatric Interventional Cardiology Devices?
What is the forecasted size of the Global Market for Pediatric Interventional Cardiology Devices?
Who are the key companies in the Global Market for Pediatric Interventional Cardiology Devices?
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | September 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2.2 Billion |
Forecasted Market Value ( USD | $ 3 Billion |
Compound Annual Growth Rate | 4.0% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Edwards Lifesciences Corporation
- GE Healthcare
- Medtronic PLC
- Siemens AG
- W. L. Gore & Associates, Inc.